Nicotinell 2 mg Fresh Mint Gum
Nicotinell 2 mg Fresh Mint Gum

Nicotinell 2 mg Fresh Mint Gum

$27.12
Size: 96
96
204
  • Estimated Delivery:Dec 03 - Dec 07

  • Free Shipping: for all orders over $40

STANDARD ITEM delivery in 7-14 days Click here for Shipping Policy
Product Information

 

Nicotinell 2 mg fresh mint is a gum that helps people quit smoking. It has nicotine, the same stuff that's in cigarettes, but instead of smoking, you chew this gum.

Here's how you use it: When you feel like smoking, instead, you chew a gum. You should do this slowly until the taste gets strong. Then, put it between your cheek and gums. Once the taste fades, you can chew it again. This process can last about 30 minutes.

Try to chew a gum every 1 to 2 hours, which is about 8 to 12 gums a day. However, don't chew more than 25 gums in a day. Your treatment should last for at least 3 months, gradually chewing fewer gums each day. When you're down to 1-2 gums a day, you can stop. But don't use it for more than 6 months unless your doctor tells you to.

Be careful not to chew too many gums because you could get nicotine overdose. The symptoms include weakness, sweating, nausea, vomiting, and even seizures which can be deadly. If this happens, contact a doctor.

Also, don't let kids get these gums. Even small amounts of nicotine can be very harmful to them.

This gum is not for you if you're allergic to nicotine or any other ingredients in it, or if you're not a regular smoker. And if you have certain health conditions, like heart problems, high blood pressure, liver or kidney problems, or certain other illnesses, you should ask your doctor before using this gum.

Also, this gum might interact with other medicines you're taking. So, make sure to tell your doctor about any other medicines you're on. And, avoid drinking fizzy, acidic drinks and coffee 15 minutes before chewing the gum.

Pregnant women should avoid smoking as it's harmful to them and their baby. If you're breastfeeding, you shouldn't use the gum within two hours before breastfeeding because nicotine can pass into breast milk.

Lastly, this gum might have some side effects like headaches, dizziness, hiccups, and mouth irritation. If you chew the gum more slowly, these might lessen. If you get serious side effects like heart rhythm problems or allergic reactions, stop using the gum and call a doctor.

Please read the following full disclosure:

SUMMARY OF PRODUCT CHARACTERISTICS

ANSM - Updated on: 22/11/2021

  1. NAME OF THE MEDICINE

NICOTINELL FRESH MINT 2 mg SUGAR-FREE, medicated chewing gum

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Nicotine ............................................................................................................................. 2.00 mg

In the form of nicotine-polacriline (1: 4) ............................................................................ 10.00 mg

For a medicated chewing gum.

Excipients: Sorbitol (0.1 g), and butylhydroxytoluene (E 321).

For the full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Medicated chewing gum.

White rectangular-shaped gum.

  1. CLINICAL DATA

4.1. Therapeutic indications

This medicine is indicated in the treatment of tobacco dependence to relieve the symptoms of nicotine withdrawal in people wishing to stop their tobacco consumption.

Appropriate support improves the chances of success in quitting tobacco.

4.2. Dosage and method of administration

Dosage

Adults over 18 years and elderly

Patients must stop smoking completely during treatment with this medicine.

The 2 mg dosage chewing gums are not recommended for smokers who are highly or very highly dependent on nicotine.

The initial dosage will be personalized according to the nicotine dependence of the individual.

In case of side effects when using 4 mg dosage chewing gums, switch to the 2 mg dosage chewing gums.

The initial dosage should be determined according to individual needs based on nicotine dependence.

Chew a gum each time the urge to smoke arises.

The consumption of 2 mg dosage chewing gums is generally 8 to 12 gums per day and should never exceed 24 gums per day. Do not use more than one gum per hour.

The characteristics of this pharmaceutical form are such that the nicotine levels obtained can vary from one individual to another. The frequency of administration will be adjusted accordingly, depending on individual needs within the limit of the maximum dosage.

The duration of treatment is individual. Normally, this treatment should be continued for at least three months.

After three months, the patient should gradually reduce the number of gums per day until the treatment is completely stopped.

Treatment will be stopped when consumption is reduced to 1 to 2 gums per day.

It is generally recommended not to use the chewing gums beyond 6 months. However, some "ex-smokers" may need longer treatment to avoid relapses. Patients who have used a nicotine substitute beyond 9 months are advised to seek advice from a health professional.

Advice from a health professional can help a smoker quit tobacco.

This medicine does not contain sugar.

Children and Adolescents

NICOTINELL FRESH MINT 2 mg sugar-free, chewing gum should not be administered to individuals under 18 years of age without medical advice. There is no experience with the administration of this medicine to individuals under 18 years of age.

Renal and Hepatic Insufficiency

This medicine should be used with caution in patients with moderate to severe renal and/or hepatic insufficiency, as the clearance of nicotine or its metabolites may be decreased with an increased potential for side effects.

Method of Administration

· Chew the gum until the taste becomes strong.

· Place the gum between the gum and the cheek.

· When the taste fades, chew the gum again.

· Alternate chewing and pauses for 30 minutes.

The intake of acidic drinks such as coffee or soda can decrease the absorption of nicotine through the oral mucosa. These drinks should be avoided for 15 minutes before taking a chewing gum.

4.3. Contraindications

· Hypersensitivity to nicotine, liquorice or any of the excipients listed in section 6.1.

· NICOTINELL FRESH MINT 2 mg sugar-free, chewing gum should not be used by non-smokers.

4.4. Special warnings and precautions for use

In case of recent myocardial infarction, unstable or worsening angina (including Prinzmetal angina), severe heart rhythm disorder, unstable hypertension or recent cerebrovascular accident which are considered hemodynamically unstable, complete cessation of tobacco use with non-pharmacological treatments should always be recommended.

In case of failure in these nicotine-dependent smokers, the use of NICOTINELL FRESH MINT 2 mg chewing gum can be considered; however, as clinical safety data in these patients are limited, treatment initiation should only be under medical supervision. In case of clinically significant increase in cardiovascular or other effects attributable to nicotine, the dosage of Nicotinell FRESH MINT 2 mg should be reduced or the medication stopped.

Use NICOTINELL chewing gum with caution in patients with hypertension, stable angina, cerebrovascular disorder, occlusive peripheral arterial diseases, heart failure, severe hepatic and/or renal insufficiency, hyperthyroidism, pheochromocytoma, and diabetes mellitus. Blood sugar may be more variable when quitting smoking, with or without nicotine replacement therapy. Therefore, it is important for diabetics to closely monitor their blood sugar when using this product.

Seizures: Use with caution in subjects taking anticonvulsant treatment or with a history of epilepsy as seizures have been reported in association with nicotine.

In these patients, complete cessation of tobacco use without nicotine replacement therapy should first be recommended.

Swallowed nicotine can exacerbate symptoms in subjects suffering from oesophagitis, oral or pharyngeal inflammation, gastritis or gastric ulcer.

Nicotine doses tolerated in smoking adults can cause serious or even fatal poisoning in young children (see section 4.9).

Keep out of the sight and reach of children.

Wearers of dentures may have difficulty chewing the gums: in this case, it is recommended to use another pharmaceutical form of nicotine replacement.

NICOTINELL FRESH MINT, medicated chewing gum may loosen fillings or dental implants.

Special warnings related to excipients:

This medicine contains sorbitol. Consequently, patients with rare hereditary problems of fructose intolerance should not take this medicine.

NICOTINELL FRESH MINT 2 mg gums contain sweeteners, including 0.1 g/gum of sorbitol (E420), source of fructose at a rate of 0.02 g/gum. The caloric intake of each gum is 1.2 Kcal/gum.

This medicine contains less than 1 mmol (23 mg) of sodium per chewing gum, i.e., it is essentially sodium-free.

This medicine contains butylhydroxytoluene (E321), which can cause local irritation of the oral mucosa.

4.5. Interactions with other medicinal products and other forms of interactions.

There are no relevant clinical data on possible interactions between chewing gums containing nicotine and other drugs.

Tobacco withdrawal itself requires some therapeutic adjustments. Smoking, but not nicotine, is associated with an increase in the activity of the CYP1A2 enzyme. Quitting smoking may result in a decrease in the clearance of substrates of this enzyme and an increase in plasma levels of certain drugs metabolised by CYP1A2, particularly molecules with a narrow therapeutic margin such as theophylline, tacrine, olanzapine and clozapine.

Furthermore, the increase in subcutaneous insulin absorption that may occur when quitting smoking may require a decrease in the dose of insulin.

4.6. Fertility, pregnancy and lactation

Pregnancy

Smoking during pregnancy is associated with reproductive risks and intrauterine growth retardation. It is initially recommended to advise pregnant women to quit smoking without the help of nicotine replacement therapy. If this fails, the use of a nicotine substitute may be considered. However, the use of an oral nicotine substitute can only be offered after estimating that the benefits to the mother outweigh the potential risks to the fetus.

Breastfeeding

Nicotine passes into breast milk in quantities that could affect the child even at therapeutic doses.

NICOTINELL gum, like smoking, should therefore be avoided during breastfeeding.

If quitting smoking is not achieved, the use of the gum during breastfeeding will only be decided on medical advice.

If this medicine is used during breastfeeding, take the gum just after feeding and do not take it during the two hours before the next feed. The use of an oral nicotine substitute can only be administered after estimating that the benefits to the mother outweigh the potential risks to the child.

Fertility

Smoking increases the risk of infertility in women and men. Both in men and in animals, it has been shown that nicotine can harm the quality of sperm. In animals, a decrease in fertility has been demonstrated.

4.7. Effects on the ability to drive and use machines

There is no evidence of risk regarding driving vehicles or operating machines when treated with gums at recommended doses. However, it should be considered that quitting smoking can cause behavioural changes.

4.8. Adverse effects

The nicotine in chewing gums can cause side effects similar to those of nicotine absorbed through smoking due to the pharmacological effects of nicotine, which are dose-dependent. Non-dose dependent side effects are: masticatory pain, urticaria, hypersensitivity, Quincke's edema, and anaphylactic shocks.

Most reported side effects occur during the first 3 to 4 weeks of treatment.

The nicotine delivered by the gums can sometimes cause a mild throat irritation and increased saliva production at the start of the treatment.

Swallowing too much nicotine can cause hiccups. Individuals suffering from digestive disorders may experience mild signs of dyspepsia or gastric burns at the start of treatment. These symptoms can be relieved by chewing the gum more slowly.

Excessive consumption of chewing gums by individuals who did not inhale tobacco smoke can cause nausea, dizziness, and headaches.

The appearance of aphthous ulcers may be more frequent when quitting smoking.

In case of adhesion, the gums can in rare cases cause an alteration of dentures or dental fillings.

Certain symptoms such as dizziness, headaches, and insomnia may be related to smoking cessation and may be due to the administration of an insufficient dose of nicotine.

Cold sores can occur when quitting smoking, but their relationship with nicotine treatment is not established.

The patient may remain dependent on nicotine after quitting smoking.

Reporting of suspected adverse reactions

Reporting of suspected adverse reactions after authorization of the drug is important. It allows for continuous monitoring of the benefit/risk ratio of the drug. Healthcare professionals report any suspected adverse reaction via the national reporting system: French National Agency for Medicines and Health Products Safety (ANSM) and network of Regional Pharmacovigilance Centres - Website: www.signalement-sante.gouv.fr.

4.9. Overdose

In case of overdose, symptoms corresponding to high tobacco consumption may be observed.

The acute lethal oral dose is about 0.5 to 0.75 mg of nicotine per kg of weight, which corresponds to 40 to 60 mg in an adult.

Even small doses of nicotine are toxic in children and can cause symptoms of intoxication which can be fatal. If suspected intoxication in a child, immediately consult a doctor.

An overdose with nicotine gums can only occur if several gums are chewed at the same time. Generally, the toxicity of nicotine after ingestion is minimized by the early occurrence of nausea and vomiting.

The risk of poisoning by swallowing the gum is low. The release of nicotine from the gum being slow, the amount of nicotine absorbed by the stomach and intestine is very low and if there was any, it would be inactivated at the liver level.

Signs and symptoms of an overdose should be the same as those of acute nicotine poisoning including: general weakness, sweats, pallor, hyperhidrosis, hypersalivation, sore throat, nausea, vomiting, diarrhea, abdominal pain, auditory and visual disturbances (sensory disturbances), headaches, dizziness, tremors, confusion, and fatigue. Prostration, hypotension, cardiovascular collapse, coma, respiratory failure, and terminal convulsions can occur in case of significant overdose.

Overdose treatment:

In case of overdose (for example, too many gums chewed), immediate medical assistance is required. Any nicotine intake should immediately stop, and the patient should be treated symptomatically and their vital signs monitored.

  1. PHARMACOLOGICAL PROPERTIES 

    5.1. Pharmacodynamic properties

    Pharmacotherapeutic group: MEDICINES USED IN NICOTINE DEPENDENCE, ATC code: N07BA01.

    Mechanism of action

    Nicotine, the main alkaloid of tobacco-derived products, is a natural substance acting on the autonomic nervous system. It is an agonist of nicotinic receptors in the central and peripheral nervous systems and has pronounced effects on the central nervous system and the cardiovascular system. When consumed via tobacco, nicotine creates a dependency resulting in a craving and other withdrawal symptoms upon cessation of administration. These withdrawal symptoms include a strong desire to smoke, dysphoria, insomnia, irritability, frustration or anger, anxiety, difficulty concentrating, restlessness, and increased appetite or weight gain. The chewing gum replaces some of the nicotine that would have been administered by the tobacco and reduces the intensity of withdrawal symptoms and the strong desire to smoke.

    5.2. Pharmacokinetic properties

    Absorption

    When the gum is chewed, nicotine is regularly released into the mouth and is rapidly absorbed at the level of the oral mucosa. Due to the swallowing of saliva containing nicotine, a certain amount of nicotine reaches the stomach and intestines where it is inactivated.

    Distribution

    The maximum plasma concentration after single administration of a 2 mg gum is approximately 6.4 ng/ml (after 45 minutes) (the average plasma nicotine concentration after a cigarette is 15 to 30 ng/ml).

    Elimination

    Nicotine elimination is mainly by hepatic metabolism; small amounts of nicotine are excreted unchanged in the urine. The plasma half-life is about 3 hours.

    Nicotine crosses the blood-brain barrier, the placenta, and is detectable in breast milk.

    5.3. Preclinical safety data

    Nicotine has tested positive in some in vitro genotoxicity tests; however, negative results have also been obtained with these same tests. Nicotine tested negative in in vivo tests.

    Animal experiments have shown that nicotine causes post-implantation loss and decreases fetal growth.

    Carcinogenicity tests have not provided clear evidence of a carcinogenic effect of nicotine.

    1. PHARMACEUTICAL DATA

    6.1. List of excipients

    Gum base (containing butylhydroxytoluene (E321)), calcium carbonate, sorbitol (E420), anhydrous sodium carbonate, sodium bicarbonate, polacrilin, glycerol (E422), purified water, levomenthol, natural mint flavor, mint perfume, sucralose, potassium acesulfame, xylitol (E967), mannitol (E421), gelatin, titanium dioxide (E171), Carnauba wax, talc.

    6.2. Incompatibilities

    Not applicable.

    6.3. Shelf life

    30 months

    6.4. Special precautions for storage

    Store at a temperature not exceeding 25°C.

    6.5. Nature and contents of outer packaging

    2 or 12 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    Boxes of 2, 12, 24, 36, 48, 60, 72, 96, 120 or 204.

    Not all pack sizes may be marketed.

    6.6. Special precautions for disposal and other handling

    Disposal of used gums should be done with caution.

    1. MARKETING AUTHORISATION HOLDER

    GLAXOSMITHKLINE CONSUMER HEALTHCARE

    23 RUE FRANCOIS JACOB

    92500 RUEIL MALMAISON

    1. MARKETING AUTHORISATION NUMBER(S)

    · 363 146-8 or 34009 363 146 8 9: 2 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 147-4 or 34009 363 147 4 0: 12 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 148-0 or 34009 363 148 0 1: 24 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 149-7 or 34009 363 149 7 9: 36 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 150-5 or 34009 363 150 5 1: 48 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 151-1 or 34009 363 151 1 2: 60 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 152-8 or 34009 363 152 8 0: 72 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 363 153-4 or 34009 363 153 4 1: 96 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 373 303-9 or 34009 373 303 9 8: 120 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    · 393 954-5 or 34009 393 954 5 6: 204 chewing gums in thermoformed blisters (PVC/PVDC/Aluminium).

    1. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

    16/12/2003

    1. DATE OF REVISION OF THE TEXT

    2. DOSIMETRY

    Not applicable.

    1. INSTRUCTIONS FOR THE PREPARATION OF RADIOPHARMACEUTICALS

    Not applicable.

    PRESCRIPTION AND DISPENSING CONDITIONS

    Over-the-counter medication.